Serologic evidence of pertussis infection in vaccinated Iranian children

Iranian Journal of Medical Sciences

Volumn 37, Issue 4, 2012, Pages 260-265

  Dashti, Anahita Sanaei ^a   Karimi, Abdollah ^a   Arjmand, Reza ^b   Moghadami, Mohsen ^a   Kheirkhah, Taherh ^c   Shiva, Farideh ^a   Gholinejad, Zari ^a   Joulaei, Hassan ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Pertussis; Pertussis vaccine; Whooping cough

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS VACCINE;

AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RATE; MALE; ONSET AGE; PERTUSSIS; PRESCHOOL CHILD; REFERENCE VALUE;

EID: 84872593911     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Kheirkhah T, Ghazanfari M, et al. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. Iran J Immunol. 2007;4:101-9. PubMed PMID: 17652850.
2. World Health Organization. Immunization Profile-Iran (Islamic Republic of) [Updated 2012 Oct 4; cited 2012 Oct 22]. Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm
3. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58-61. doi: 10.1097/01.inf.0000160914.59160.41. PubMed PMID: 15876927.
4. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ. 2005;172:509-15. doi: 10.1503/cmaj.1040766. PubMed PMID: 15710944; PubMed Central PMCID: PMC548414.
5. De Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38:800-6. PubMed PMID: 10655388; PubMed Central PMCID: PMC86208.
6. Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr. 2007;44:916-8. PubMed PMID: 18175845.
7. Halperin SA, Bortolussi R, Wort AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol. 1989;27:752-7. PubMed PMID: 2542366; PubMed Central PMCID: PMC267411.
8. Watanabe M, Connelly B, Weiss AA. Characterization of serological responses to pertussis. Clin Vaccine Immunol. 2006;13:341-8. doi: 10.1128/CVI.13.3.341-348.2006. PubMed PMID: 16522775; PubMed Central PMCID: PMC1391967.
9. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-82. doi: 10.1128/CMR.18.2.326-382.2005. PubMed PMID: 15831828; PubMed Central PMCID: PMC1082800.
10. Müller FM, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol. 1997;35:2435-43. PubMed PMID: 9316885; PubMed Central PMCID: PMC229988.
11. Mink CM, O'Brien CH, Wassilak S, Deforest A, Meade BD. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun. 1994;62:1118-20. PubMed PMID: 7509316; PubMed Central PMCID: PMC186231.
12. Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med. 1995;333:1045-50. doi: 10.1056/NEJM199510193331604. PubMed PMID: 7675047.
13. Grimprel E, Bégué P, Anjak I, Njamkepo E, François P, Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol. 1996;3:93-7. PubMed PMID: 8770511; PubMed Central PMCID: PMC170254.
14. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol. 2004;11:1045-53. PubMed PMID: 15539504; PubMed Central PMCID: PMC524757.
15. Miller E, Fleming DM, Ashworth LA, Mabbett DA, Vurdien JE, Elliott TS. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health. 2000;3:132-4. PubMed PMID: 10902257.
16. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32:1691-7. doi: 10.1086/320754. PubMed PMID: 11360208.
17. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis. 2001;183:1353-9. doi: 10.1086/319853. PubMed PMID: 11294666.
18. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. BMJ. 1988;296:612-4. doi: 10.1136/bmj.296.6622.612. PubMed PMID: 3126927; PubMed Central PMCID: PMC2545243.
19. Torvaldsen S, McIntyre PB. Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J. 2003;22:956-9. doi: 10.1097/01.inf.0000095198.75170.b6. PubMed PMID: 14614366.
20. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infec Dis. 2010;14:e1072-5. doi: 10.1016/j.ijid.2010.07.005. PubMed PMID: 20951620.